CNSP - CNS Pharmaceuticals, Inc.
1.14
0.020 1.754%
Share volume: 31,908
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.12
0.02
0.02%
Summary score
30%
Profitability
25%
Dept financing
9%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-46601.94%
Return on assets
-43.21%
Return on sales
0%
Return on invested capital
1063.99%
Total debt ratio
87.81%
Debt ratio change over timeo
0%
Current Ratio
6.93%
Quick Ratio
0%
Cash Position Ratio
5.47%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-60.31%
Return on assets
-53.78%
Return on sales
0%
Return on invested capital
2253.1%
Total debt ratio
9.2%
Debt ratio change over timeo
0%
Current Ratio
15.15%
Quick Ratio
0%
Cash Position Ratio
11.97%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-81.27%
Return on assets
-67.37%
Return on sales
0%
Return on invested capital
4820.15%
Total debt ratio
17.11%
Debt ratio change over time
0%
Current Ratio
4.93%
Quick Ratio
0%
Cash Position Ratio
2.56%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CNSP | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -46601.94% | 18.71% | 4.67% | 19.62% |
| Return on assets | -43.21% | 3.4% | 3.32% | 11.24% |
| Return on sales | 0% | 24.27% | 25.81% | 41.89% |
| Return on invested capital | 1063.99% | 5.38% | 4.17% | -280.52% |
| Profitability | 25% | 46% | 29% | 75% |
| Total debt ratio | 87.81% | 78.91% | 58.54% | 54.01% |
| Debt ratio change over time | 0% | 0% | 10.69% | 0% |
| Dept financing | 25% | 22% | 42% | 15% |
| Current Ratio | 15.15% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 11.97% | 0.21% | 0.6% | 0.32% |
| Liquididy | 50% | 27% | 33% | 22% |
| Short-term ratios | CNSP | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -60.31% | 41.05% | 6.87% | 16.13% |
| Return on assets | -53.78% | 3.67% | 3.13% | 8.75% |
| Return on sales | 0% | 26.16% | 24.75% | 38.84% |
| Return on invested capital | 2253.1% | 9.43% | 5.58% | -6.74% |
| Profitability | 25% | 52% | 29% | 60% |
| Total debt ratio | 9.2% | 91.28% | 61.3% | 55.02% |
| Debt ratio change over time | 0% | 0% | 13.89% | 0% |
| Dept financing | 3% | 25% | 42% | 15% |
| Current Ratio | 15.15% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 11.97% | 0.21% | 0.6% | 0.32% |
| Liquididy | 50% | 24% | 28% | 21% |
